Hold Nestlé India Ltd For Target Rs.20,450 - ICICI Direct
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Sanand plant to aid growth of core categories…
About the stock Nestlé India (NIL) is the largest food company in India with over | 13000 crore of sales. It is broadly present in infant & baby food products, noodles, chocolates & beverages categories. In the last five years, the company has forayed into newer categories and launched more than 80 new products.
* The company has eight manufacturing facilities while a new plant in Sanand, Gujarat got commissioned during the quarter. Its major brands include Maggi, Nescafe, KitKat, Cerelac among others
Q3CY21 Results: Nestlé India reported Q3FY21 results.
* Sales were up 9.6% YoY with strong traction in core brands
* EBITDA was at | 948.5 crore, up 7.3% YoY, with margins at 24.4%
* Consequent PAT was at | 617.9 crore (up 5.2% YoY)
What should investors do? Nestlé India’s share price has given return of 180% in the last five years (from | 6869 in October 2016 to | 19278 in October 2021). We maintain our estimates with sustainable sale growth in core brands as supply issues resolved by commissioning of new manufacturing facility
* We continue to maintain our HOLD rating on the stock
Target Price and Valuation: We value the stock at | 20450, valuing the business 65x FY24 earnings
Key triggers for future price performance:
* The company is undertaking a capex of | 2600 crore in the next three to four years to expand the capacity of its existing products
* NIL is increasing its rural footprint from 0.9 lakh villages to 1.2 lakh villages in the next four years
* With the reduction in Covid-19 cases & vaccination drive, urban demand is likely to pick up. The product portfolio of NIL is urban centric
* Commissioning of Sanand facility would aid revenue growth in core brands given packaged foods saw high demand in the last 18 months
Alternate Stock Idea: We like Zydus Wellness in our FMCG coverage.
* It is growing at a steady pace in nascent categories with strong presence in health, nutrition space & margin expansion possibilities
* Trading at significant discount to FMCG peers. BUY with TP of | 2,800
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
Above views are of the author and not of the website kindly read disclaimer
